Skip to main content
SpringerLink
Log in

Revisions made for crizotinib-related cardiac failure in Japan

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ministry of Health, Labour & Welfare. Important Safety Information - Crizotinib. Pharmaceuticals and Medical Devices Safety Information : 8-11, No. 324, Jul 2015. Available from: URL: http://www.pmda.go.jp/files/000206499.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Revisions made for crizotinib-related cardiac failure in Japan. Reactions Weekly 1564, 6 (2015). https://doi.org/10.1007/s40278-015-4149-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-4149-y

Search

Navigation